NEWARK- ILC Doverthe company specializing in engineering, development and manufacturing, announced on Monday that it was investing in a major production expansion in Poland.
The new facility will be built in Gliwice, Poland, approximately 300 km southwest of Warsaw, near the border with the Czech Republic. This is the second major international expansion announced this year for ILC Dover. In March, the company announcement that it was expanding its nearly decade-old factory in Juarez, Mexico, near the Texas border town of El Paso.
The “state-of-the-art” 90,000 square foot Polish facility will be equipped with a clean room capacity of 20,000 square feet to manufacture single-use powder bags, single-use liquid bags and disposable fluid transfer sets. The new site would provide redundant sourcing capabilities and reduce delivery times for its European and Asian customers, while meeting its quality standards. ILC Dover aims to open the factory in early 2023.
The facility will employ 250 people at full capacity, joining ILC Dover’s more than 2,000 employees worldwide, the company said. It complements the current global biopharmaceutical manufacturing footprint of ILC Dover in Frederica, as well as Juarez, Durham, NC; Stockport, UK; Rossens, Switzerland; and Blarney, Ireland.
While many in Delaware are likely to know ILC Dover for its connection to NASA astronaut space suits dating back to the Apollo missions, the company has largely refocused in recent years on space biopharmaceuticals, equipment manufacturing and materials used in the production of drugs, vaccines and more. as well as in cell and gene therapy research.
“We are very pleased to expand our global footprint in Poland with a new manufacturing facility equipped with the capability to better serve our growing European and APAC customer base,” Corey Walker, CEO of ILC Dover, said in a statement. “Providing mission-critical solutions to leading global life science customers remains a top priority as our strategic investments focus on ways to improve and optimize their workflows.”
The plant’s recent expansions are among the first major initiatives since the change of CEO in November, when Walker, a veteran in life sciences, advanced technologies and applied materials, took over.
This change capped two years of change at the ILC, which moved its headquarters at the University of Delaware’s STAR campus from its longtime Federica factory in January. New Mountain Capital, a New York-based company with $35 billion in assets under management, acquired ILC in February 2020 as part of a deal with another private equity firm, Behrman Capital.
The new chief executive came to Delaware after working closely with the owner of ILC’s private equity firm, New Mountain Capital, from 2016 to 2020. He was then a senior executive at Avantor, a chemical company and materials headquartered outside of Philadelphia, as executive vice president of the Americas, as well as the global biomaterials and electronic materials businesses.
In December, Walker also oversaw the acquisition of KSE Scientific, a manufacturer of sterile solutions specializing in the production of water for injection for the biopharmaceutical, cell and gene therapy, tissue banking and device end markets. medical. Founded in 2000 and based in Durham, NC, KSE is a leading supplier of sterile consumable products and will continue to operate under its own brand.